"290932" . "Objectives: The patient's subjective well-being and attitude toward antipsychotic medication are considered to be important for compliance. Methods: Self-rating Well-being Neuroleptic Scale (SWN) was applied to evaluate the patients' subjective well-being.We also administered the Drug Attitude Inventory (DAI) to evaluate the attitude of the study subjects toward antipsychotic medication. Results: Seventy-five outpatients (women N = 25) at the average age of 34.6 years (median 32 years) with the diagnosis of schizophrenia were included into the study. The patients with the most pronounced subjective well-being were in remission, treated with monotherapy, and low doses of antipsychotic drugs. Conclusion: Subjective well-being is increasingly being accepted as a valid and important measure of antipsychotic treatment outcomes and tolerability."@en . "Subjective Well- Being of Patients on Antipsychotic Treatment" . "S" . "3"^^ . "New York" . "1000"^^ . "Neuveden" . . "978-1-61761-002-8" . "Yearbook of International Psychiatry and Behavioral Neurosciences - 2009" . . . . "[DD1BE4B4AE12]" . "5"^^ . . . . "Subjective Well- Being of Patients on Antipsychotic Treatment" . . . . "RIV/00216208:11150/10:10069759!RIV11-MSM-11150___" . "Masopust, Ji\u0159\u00ED" . "K\u00F6hler, Richard" . . . "Subjective Well- Being of Patients on Antipsychotic Treatment"@en . "adverse events of antipsychotic; remission; monotherapy; attitude toward medication; subjective well-being"@en . "Nova Science Publishers" . "Subjective Well- Being of Patients on Antipsychotic Treatment"@en . "Objectives: The patient's subjective well-being and attitude toward antipsychotic medication are considered to be important for compliance. Methods: Self-rating Well-being Neuroleptic Scale (SWN) was applied to evaluate the patients' subjective well-being.We also administered the Drug Attitude Inventory (DAI) to evaluate the attitude of the study subjects toward antipsychotic medication. Results: Seventy-five outpatients (women N = 25) at the average age of 34.6 years (median 32 years) with the diagnosis of schizophrenia were included into the study. The patients with the most pronounced subjective well-being were in remission, treated with monotherapy, and low doses of antipsychotic drugs. Conclusion: Subjective well-being is increasingly being accepted as a valid and important measure of antipsychotic treatment outcomes and tolerability." . "RIV/00216208:11150/10:10069759" . . "11150" . . "Libiger, Jan" . "3"^^ . . . . .